Inventor
PORDY ROBERT C
US10 patents
⚠️ This page may combine multiple inventors who share the name “PORDY ROBERT C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
6 patentsUS9724411B2Aug 8, 2017
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
REGENERON PHARMA15 citations83
US10111953B2Oct 30, 2018
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
REGENERON PHARMA15 citations82
US10772956B2Sep 15, 2020
Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab
REGENERON PHARMA8 citations79
US11904017B2Feb 20, 2024
Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab
REGENERON PHARMA3 citations70
US10934349B2Mar 2, 2021
Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody
REGENERON PHARMA2 citations70
US12029788B2Jul 9, 2024
Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody
REGENERON PHARMA0 citations60
SANOFI BIOTECHNOLOGY
3 patentsUS10428157B2Oct 1, 2019
Dosing regimens for use with PCSK9 inhibitors
SANOFI BIOTECHNOLOGY8 citations81
US11306155B2Apr 19, 2022
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
SANOFI BIOTECHNOLOGY5 citations80
US10544232B2Jan 28, 2020
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody
SANOFI BIOTECHNOLOGY9 citations80